0 items USD 0.00Search
- Did you mean
- non receptor tyrolit protein kinase
Your search for "Non Receptor Tyrosine Protein Kinase" gave back 14942 results.
Quizartinib is a small molecule receptor tyrosine kinase inhibitor. The global Quizartinib market was valued at US$ million in 2023 and is...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Quizartinib is a small molecule receptor tyrosine kinase inhibitor. The global Quizartinib market was valued at US$ million in 2022 and is...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Quizartinib is a small molecule receptor tyrosine kinase inhibitor. The global Quizartinib market is projected to grow from US$ million in 2023 to US...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Ibrutinib is an orally bioavailable, small-molecule inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. Upon...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
The global 4',5,7-Trihydroxyisoflavone market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the...
Catalog:
GIR
December 2023
Price: USD 4,480.00
L-Tyrosine or tyrosine or 4-hydroxyphenylalanine is one of the 20 standard amino acids that are used by cells to synthesize proteins. It is a non-...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
L-Tyrosine or tyrosine or 4-hydroxyphenylalanine is one of the 20 standard amino acids that are used by cells to synthesize proteins. It is a non-...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Ibrutinib is an orally bioavailable, small-molecule inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. Upon...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
The global 4',5,7-Trihydroxyisoflavone market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029...
Catalog:
GIR
December 2023
Price: USD 3,480.00
Ensartinib is an orally available small molecule inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with potential...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Dovitinib is multi-kinase inhibitor. The global Dovitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030,...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Dovitinib is multi-kinase inhibitor. The global Dovitinib market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Ensartinib is an orally available small molecule inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with potential...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Ensartinib is an orally available small molecule inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with potential...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Lestaurtinib inhibits JAK2, FLT3, and TrkA with IC50s of 0.9, 3, and less than 25 nM, respectively. Lestaurtinib is a multi-kinase inhibitor. It also...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
